Purchase Order SPE2DS25P1107
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,915.20 firm fixed-price purchase order to Zoll Medical Corporation for an Enhancer Circulator, with performance expected to conclude by December 1, 2025. This contract, which carries no set-aside designation, will be performed at Zoll's facility in Chelmsford, Massachusetts. The award reflects a routine procurement from the vendor's existing contract vehicle, leveraging Zoll's established relationship with DLA for medical equipment...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,368 firm fixed-price purchase order to Zoll Medical Corporation for an Enhancer Circulator device. The contract, issued on September 19, 2025, with an ultimate completion date of November 18, 2025, will be performed at Zoll's facility in Chelmsford, Massachusetts. No set-aside designation was used for this procurement. Zoll Medical Corporation, a foreign-owned medical device manufacturer, is a primary supplier of emergency medical...
- Zoll Medical Corporation has been awarded a $4,104 firm fixed-price purchase order for an enhancer circulator, a critical medical device component. The contract, awarded on September 29, 2025, by the Medical Supply Chain division of the Department of Defense, carries a completion deadline of December 1, 2025, and will be performed at Zoll's headquarters in Chelmsford, Massachusetts. This procurement was not set aside for any specific business designation and represents a routine supply order...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Zoll Medical Corporation, a foreign-owned, for-profit medical device manufacturer. The $1,332.00 firm fixed-price purchase order is for an "ENHANCER,CIRCULATOR" item, with a performance period ending on May 6, 2025. This award is not a set-aside contract. Zoll Medical Corporation has a significant $81 million Indefinite Delivery Contract with the DLA Troop Support Medical branch, enabling rapid procurement of...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $2,115 firm fixed-price purchase order to Zoll Medical Corporation on September 17, 2025, with an ultimate completion date of November 17, 2025. The contract, which was not set aside for any specific business designation, will be performed at Zoll's headquarters in Chelmsford, Massachusetts. Zoll Medical Corporation, a foreign-owned medical device manufacturer, is a primary supplier of advanced emergency medical...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation on July 18, 2025, for defibrillator/monitor equipment. The contract, with an ultimate completion date of September 16, 2025, will be performed at Zoll's facility in Chelmsford, Massachusetts. This award was not set aside for any specific business designation and represents a continuation of Zoll's substantial role as a critical medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price purchase order valued at $6,962.34 to Zoll Medical Corporation for defibrillator and monitoring equipment on July 21, 2025. The contract, with an ultimate completion date of September 19, 2025, will be performed at Zoll's facility in Chelmsford, Massachusetts. This award was not designated as a set-aside contract and represents a routine procurement action typical of DLA's ongoing medical equipment supply...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Zoll Medical Corporation, a foreign-owned, for-profit medical device manufacturer, for the supply of an "ENHANCER,CIRCULATOR" item. The contract has a ceiling value of $1,984.40 and an ultimate completion date of May 27, 2025. This contract is not set-aside and is likely a delivery order under Zoll's existing $81 million Indefinite Delivery Contract with the DLA Troop Support Medical...
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Zoll Medical Corporation, a foreign-owned, for-profit medical device manufacturer. The contract, valued at $3,996.00, is for the delivery of ENHANCER,CIRCULATOR equipment. The contract is not set-aside and is part of a larger $81 million Indefinite Delivery Contract with the DLA Troop Support Medical branch, which enables rapid procurement of medical technologies for military and federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a four-year maintenance delivery order to Zoll Medical Corporation on August 20, 2025, with an ultimate completion date of March 30, 2026. This fixed-price contract with economic price adjustment provisions carries a ceiling value of $1,277.10 and will be performed at Zoll's facility in Chelmsford, Massachusetts. The contract does not utilize any set-aside designation and represents a continuation of Zoll's extensive...
The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $2,736 firm fixed-price purchase order to Zoll Medical Corporation for an enhancer circulator on May 30, 2025. The contract, which carries an ultimate completion date of July 29, 2025, represents a routine procurement of specialized medical equipment with no set-aside designation applied. Zoll Medical Corporation, a foreign-owned medical device manufacturer headquartered in Chelmsford, Massachusetts, will perform the work at its Chelmsford facility. This award falls under Zoll's broader relationship with the Defense Logistics Agency, which includes an $81 million indefinite delivery contract with DLA Troop Support Medical that enables rapid procurement of critical medical technologies for military and federal healthcare facilities. Zoll Medical has established itself as a significant supplier of emergency medical equipment and critical care solutions to federal agencies, with a comprehensive federal supply schedule contract valued at $23.4 million with the Department of Veterans Affairs and multiple delivery orders across various government entities. The company's product portfolio includes defibrillators, ventilators, patient monitors, and specialized medical devices that support military, emergency medical services, and veteran healthcare systems. This purchase order for the enhancer circulator aligns with Zoll's core mission of providing essential medical equipment to support federal healthcare operations across defense and civilian medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/30/25 |